Shanghai Pharmaceuticals

News

Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.

News

GSK's antisense-based drug for chronic hepatitis B virus (HBV) infection, Hibsago, has been approved in the US, its second major market after Japan.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.